A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria

被引：0

作者：

Fiona Macintyre

Yeka Adoke

Alfred B. Tiono

Tran Thanh Duong

Ghyslain Mombo-Ngoma

Marielle Bouyou-Akotet

Halidou Tinto

Quique Bassat

Saadou Issifou

Marc Adamy

Helen Demarest

Stephan Duparc

Didier Leroy

Bart E. Laurijssens

Sophie Biguenet

Afizi Kibuuka

Antoinette Kitoto Tshefu

Melnick Smith

Chanelle Foster

Illse Leipoldt

Peter G. Kremsner

Bui Quang Phuc

Alphonse Ouedraogo

Michael Ramharter

机构：

[1] Medicines for Malaria Venture,Infectious Diseases Research Collaboration

[2] Tororo Hospital,Universite des Sciences de la Sante Gabon, Département de Parasitology, Malaria Clinical and Operational Research Unit

[3] Centre National de Recherche et de Formation sur le Paludisme,Centre de Recherche du Centre Hospitalier de Mont Amba, Kinshasa School of Public Health

[4] National Institute of Malariology,Department of Medicine I, Division of Infectious Diseases

[5] Parasitology and Entomology,undefined

[6] Centre de Recherches Médicales de Lambaréné,undefined

[7] Institut für Tropenmedizin,undefined

[8] Universität Tübingen,undefined

[9] Melen Hospital,undefined

[10] Institut de Recherche en Sciences de la Santé – Unité de Recherche Clinique de Nanoro,undefined

[11] ISGlobal,undefined

[12] Barcelona Ctr. Int. Health Res. (CRESIB),undefined

[13] Hospital Clínic - Universitat de Barcelona,undefined

[14] Centro de Investigação em Saúde de Manhiça (CISM),undefined

[15] ICREA,undefined

[16] Pediatric Infectious Diseases Unit,undefined

[17] Pediatrics Department,undefined

[18] Hospital Sant Joan de Déu (University of Barcelona),undefined

[19] Universidad Europea de Madrid,undefined

[20] Centre de Recherche sur le Paludisme Associé à la Grossesse et l’Enfance,undefined

[21] Faculte Des Sciences De La Sante,undefined

[22] BEL Pharm Consulting,undefined

[23] University of Kinshasa,undefined

[24] QuintilesIMS,undefined

[25] Department: Biostatistics,undefined

[26] Medical University of Vienna,undefined

[27] Bernhard Nocht Hospital for Tropical Diseases,undefined

[28] Bernhard Nocht Institute for Tropical Medicine and University Medical Center Hamburg-Eppendorf,undefined

来源：

BMC Medicine | / 15卷

关键词：

Artefenomel; OZ439; Piperaquine; Single dose combination treatment; Pharmacokinetics; Dose–response; modelling and simulation; Phase II B; Uncomplicated ; malaria; Children;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[11] Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study
Held, Jana
Supan, Christian
Salazar, Carmen L. O.
Tinto, Halidou
Bonkian, Lea N.
Nahum, Alain
Moulero, Bancole
Sie, Ali
Coulibaly, Boubacar
Sirima, Sodiomon B.
Siribie, Mohamadou
Otsyula, Nekoye
Otieno, Lucas
Abdallah, Ahmed M.
Kimutai, Robert
Bouyou-Akotet, Marielle
Kombila, Maryvonne
Koiwai, Kimiko
Cantalloube, Cathy
Din-Bell, Chantal
Djeriou, Elhadj
Waitumbi, John
Mordmueller, Benjamin
Ter-Minassian, Daniel
Lell, Bertrand
Kremsner, Peter G.
LANCET INFECTIOUS DISEASES, 2015, 15 (12) : 1409 - 1419
[12] A randomized, double-blind study on the efficacy and safety of a practical three-day regimen with artesunate and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa
Massougbodji, A
Kinde-Gazard, D
Same-Ekobo, A
Cambon, N
Mueller, EA
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2002, 96 (06) : 655 - 659
[13] Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study
Offianan Andre Toure
Stephen Rulisa
Anupkumar R. Anvikar
Ballamudi S. Rao
Pitabas Mishra
Rajinder K. Jalali
Sudershan Arora
Arjun Roy
Nilanjan Saha
Sunil S. Iyer
Pradeep Sharma
Neena Valecha
Malaria Journal, 14
[14] Efficacy of artesunate plus chloroquine for the treatment of uncomplicated malaria in children in Burkina Faso:: a double-blind, randomized, controlled trial
Sirima, SB
Tiono, AB
Konaté, A
Diarra, A
Castelli, F
Pinoges, L
Mugittu, K
Taylor, WRJ
Olliaro, PL
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2003, 97 (03) : 345 - 349
[15] Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambarene, Gabon: an open-label clinical trial
Adegbite, Bayode R.
Edoa, Jean R.
Honkpehedji, Yabo J.
Zinsou, Frejus J.
Dejon-Agobe, Jean C.
Mbong-Ngwese, Mirabeau
Lotola-Mougueni, Fabrice
Koehne, Erik
Lalremruata, Albert
Kreidenweiss, Andrea
Nguyen, The T.
Kun, Jutta
Agnandji, Selidji T.
Lell, Bertrand
Safiou, Abdou R.
Atome, Fridia A. Obone
Mombo-Ngoma, Ghyslain
Ramharter, Michael
Velavan, Thirumalaisamy P.
Mordmueller, Benjamin
Kremsner, Peter G.
Adegnika, Ayola A.
MALARIA JOURNAL, 2019, 18 (01)
[16] Efficacy and safety of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan children: a systematic review and meta-analysis of randomized control trials
Dawit Getachew Assefa
Eden Dagnachew Zeleke
Delayehu Bekele
Hanna Amanuel Tesfahunei
Emnet Getachew
Michele Joseph
Tsegahun Manyazewal
Malaria Journal, 20
[17] Efficacy and Safety of Pyronaridine-Artesunate plus Single-Dose Primaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Eastern Cambodia
Leang, Rithea
Mairet-Khedim, Melissa
Chea, Huch
Huy, Rekol
Khim, Nimol
Bouth, Denis Mey
Bustos, Maria Dorina
Ringwald, Pascal
Witkowski, Benoit
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (03)
[18] Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial
Bayode R. Adegbite
Jean R. Edoa
Yabo J. Honkpehedji
Frejus J. Zinsou
Jean C. Dejon-Agobe
Mirabeau Mbong-Ngwese
Fabrice Lotola-Mougueni
Erik Koehne
Albert Lalremruata
Andrea Kreidenweiss
The T. Nguyen
Jutta Kun
Selidji T. Agnandji
Bertrand Lell
Abdou R. Safiou
Fridia A. Obone Atome
Ghyslain Mombo-Ngoma
Michael Ramharter
Thirumalaisamy P. Velavan
Benjamin Mordmüller
Peter G. Kremsner
Ayola A. Adegnika
Malaria Journal, 18
[19] Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
Stone, Will
Mahamar, Almahamoudou
Smit, Merel J.
Sanogo, Koualy
Sinaba, Youssouf
Niambele, Sidi M.
Sacko, Adama
Keita, Sekouba
Dicko, Oumar M.
Diallo, Makonon
Maguiraga, Seydina O.
Samake, Siaka
Attaher, Oumar
Lanke, Kjerstin
Ter Heine, Rob
Bradley, John
McCall, Matthew B. B.
Issiaka, Djibrilla
Traore, Sekou F.
Bousema, Teun
Drakeley, Chris
Dicko, Alassane
LANCET MICROBE, 2022, 3 (05): : E336 - E347
[20] Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants
Gargano, Nicola
Madrid, Lola
Valentini, Giovanni
D'Alessandro, Umberto
Halidou, Tinto
Sirima, Sodiomon
Tshefu, Antoinette
Mtoro, Ali
Gesase, Samwel
Bassat, Quique
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)

← 1 2 3 4 5 →